deferasirox has been researched along with desferrithiocin in 2 studies
Studies (deferasirox) | Trials (deferasirox) | Recent Studies (post-2010) (deferasirox) | Studies (desferrithiocin) | Trials (desferrithiocin) | Recent Studies (post-2010) (desferrithiocin) |
---|---|---|---|---|---|
832 | 136 | 572 | 38 | 1 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acklin, P; Alberti, D; Buehlmayer, P; Hauffe, S; Lattmann, R; Nick, H; Schupp, J | 1 |
Hider, RC; Zhou, T | 1 |
1 review(s) available for deferasirox and desferrithiocin
Article | Year |
---|---|
Development of tridentate iron chelators: from desferrithiocin to ICL670.
Topics: Animals; Benzoates; Callithrix; Chemical Phenomena; Chemistry, Physical; Deferasirox; Dihydropyridines; Dogs; Humans; Iron; Iron Chelating Agents; Rats; Thiazoles; Triazoles | 2003 |
1 other study(ies) available for deferasirox and desferrithiocin
Article | Year |
---|---|
The design of orally active iron chelators.
Topics: Administration, Oral; Benzoates; Clinical Trials as Topic; Deferasirox; Dihydropyridines; Drug Design; Drug Evaluation, Preclinical; Humans; Iron; Iron Chelating Agents; Ligands; Models, Molecular; Molecular Structure; Oxidation-Reduction; Pyridones; Thiazoles; Triazoles | 2005 |